This comprehensive review presents current research on PDE4 and its potential utility as a therapeutic target in GI and liver diseases, including inflammatory bowel diseases (IBDs), alcoholic liver disease (ALD), nonalcoholic fatty liver disease (NAFLD), liver fibrosis, digestive tract tumors, and possibly other conditions. Here, PDE4A is linked to liver disorder.